The Daily Populous

Every year, doctors at a hospital in the Yunnan Province of China brace themselves for an influx of people with an unusual complaint.

The patients come with a strikingly odd symptom: visions of pint-sized, elf-like figures – marching under doors, crawling up walls and clinging to furniture.

In Yunnan, L. asiatica is sold in markets, it appears on restaurant menus and is served at home during peak mushroom season between June and August. »

Developers at Ubisoft Paris and unionized employees are planning a coordinated walkout during a visit from CEO Yves Guillemot, after mounting backlash over the company’s recent restructuring, cost-cutting decisions, and proposed job cuts.

The French media reports on the planned protest by Ubisoft Paris workers, claiming that CEO Yves Guillemot will be met with a strike and demonstrations upon his visit to the studio, with some devs outright saying “he is not welcome.”.

Ubisoft leadership is yet to publically detail how it plans to respond to the planned protest around their CEO’s visit. »

While none of the diplomats who spoke to POLITICO were present, individual leaders briefed them separately on the content of the conversation shortly after it.

All the diplomats were granted anonymity by POLITICO to allow them to discuss the confidential exchanges between leaders.

A year ago, Fico spoke at the Conservative Political Action Conference and told Americans “your president is doing Europe a great service.”. »

But a new study from the Spanish National Cancer Research Centre (CNIO) reveals that it is possible to eliminate pancreatic tumours in mice and prevent them from recurring using triple combination therapy.

"These studies open a way to design new combination therapies that can improve the survival of patients with pancreatic ductal adenocarcinoma," the authors said in a statement.

The results, published in the scientific journal 'PNAS', show that simultaneously targeting three key points of the KRAS oncogene molecular pathway achieves long-lasting tumour regression. »